How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    Interventional procedure overview of biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer

    Closed for comments This consultation ended on at   Request commenting lead permission

    Introduction

    The National Institute for Health and Care Excellence (NICE) prepared this interventional procedure overview to help members of the interventional procedures advisory committee (IPAC) make recommendations about the safety and efficacy of an interventional procedure. It is based on a rapid review of the medical literature and professional opinion. It should not be regarded as a definitive assessment of the procedure.

    Date prepared

    This overview was prepared in July 2021 and updated in May 2022.

    Procedure name

    • Biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer

    Professional societies

    • British Uro-Oncology Group (BUG; Predominantly formed by radiation/medical oncologists)

    • British Association of Urological Surgeons (BAUS)

    • Royal College of Radiologists (RCR)

    • The Association of Coloproctology of Great Britain and Ireland.